The logic is disarmingly simple. Every cell in a mixture belongs to one person, so if investigators can physically isolate individual cells before DNA analysis, each isolated cell yields a single-source profile rather than a tangled blend. The idea is not entirely new—researchers first demonstrated DNA fingerprinting from single cells in 1997, when a team at the University of Leeds amplified DNA from a single cell and produced a usable genetic profile. What has changed is the sophistication of the isolation tools, the integration of genotype data across many cells, and the emergence of probabilistic frameworks that can turn a handful of single-cell profiles into courtroom-grade evidence. The Sichuan University review, published in October 2026, systematically evaluates these advances and charts a path toward routine forensic application.

The first family of techniques the authors examine is micromanipulation and laser capture microdissection, or LCM. Micromanipulation is the most direct approach: an operator uses a fine glass capillary under a microscope to pick out target cells one by one, a method first applied to forensic identification in sexual assault cases as early as 2008, when researchers isolated single sperm cells by micromanipulation for human identification. LCM takes a more automated approach, using a laser to cut target cells directly from a stained slide while leaving unwanted cells behind. The technique was originally developed at the National Institutes of Health in the late 1990s to open the microscopic frontier to molecular analysis, and forensic scientists quickly adapted it to separate pure spermatozoa from epithelial cells for short tandem repeat, or STR, analysis. Studies published in 2006 and later confirmed that laser microdissection could recover clean sperm profiles from sexual assault swabs, and more recent work has refined the hardware itself, including systems based on structured light modulation with dual cutting modes and negative pressure adsorption collection. The strength of these approaches is precision: the operator sees exactly which cell is being taken. The weakness is throughput, because isolating enough cells for a robust profile remains slow and labor-intensive.

The second category pairs fluorescence-activated cell sorting, known as FACS, with imaging flow cytometry, or IFC. Flow cytometry separates cells based on measurable properties: sperm cells, for example, are haploid while vaginal epithelial cells are diploid, and cells can also be distinguished by surface markers such as CD45, cytokeratin, and MHC class I expression. Researchers demonstrated sperm and vaginal cell separation by flow cytometry for DNA typing after sexual assault as early as 1999, and subsequent work extended the approach to fluorescence- and magnetic-activated cell sorting strategies for separating spermatozoa from multi-contributor biological mixtures. Imaging flow cytometry adds a crucial forensic capability: it captures high-resolution images of every cell as it flows past the detector, allowing classification based on morphological characteristics. A 2024 study showed that imaging flow cytometry could classify epidermal, buccal, penile, and vaginal epithelial cells using morphological features alone—a breakthrough for touch DNA cases, where the mixture often involves the same cell type from multiple people and where traditional separation methods fail entirely. FACS offers far higher throughput than micromanipulation, but it requires the sample to be in single-cell suspension, which means solid tissues and sticky stains must first be dissociated, a step that can damage fragile forensic material.

The third and arguably most promising category is microfluidic-based systems, represented by the DEPArray platform. This technology uses dielectrophoresis—the movement of cells in non-uniform electric fields—to trap individual cells in electronically controlled cages within a microfluidic cartridge. Operators can then image each trapped cell and selectively release only the cells of interest, achieving a digital precision that earlier methods could not match. Studies published in 2017 demonstrated the isolation and genetic analysis of pure cells from forensic biological mixtures with this approach, and subsequent research showed enhanced DNA mixture deconvolution of sexual offense samples. A 2024 validation study for forensic applications confirmed the technology’s reliability, and other work has applied it to the deconvolution of blood-blood mixtures using separated single-cell STR profiling—one of the most challenging mixture types in forensic practice. The platform’s precision comes at a cost, however: throughput is limited by the cartridge capacity, and the expense of the system places it beyond many routine laboratories. Newer microfluidic innovations, including integrated dielectrophoretic presorting with wireless electrode arrays for high-throughput selective single-cell isolation published in 2026, and forensic lab-on-a-disc devices for enhanced sperm cell purification, suggest the field is actively working to close the throughput gap.

Isolating a cell is only half the battle. Once a single cell is captured, its DNA must be amplified, and this is where the technique encounters its most stubborn technical obstacles. A single cell contains roughly six picograms of DNA, so whole genome amplification is required before STR typing. At this extreme low-template regime, two artifacts dominate: allelic drop-out, in which one allele at a locus fails to amplify and produces a false homozygous result, and allelic drop-in, in which stray DNA from the environment contaminates the amplification and introduces alleles that were never in the original cell. Drop-out rates in single-cell STR profiles can exceed thirty percent at some loci, and stutter—artifactual peaks one repeat unit shorter than the true allele—behaves differently in single cells than in bulk samples, complicating interpretation. Researchers have developed increasingly refined amplification chemistries to mitigate these problems, including abasic-site-mediated semi-linear preamplification for low-template DNA published in 2025, and recombinase polymerase amplification of forensic STR loci, which operates at constant temperature and could enable rapid point-of-care typing.

The real forensic power emerges when investigators analyze not one cell but many, and then integrate the genotype data computationally. Because each cell carries the same genome from one contributor, clustering algorithms can group single-cell profiles by their underlying genotype, and consensus reconstruction can correct for drop-out by combining information across replicates. Research from the group of Kristen Duffy and Catherine Grgicak demonstrated that single-cell data produces genotype distributions concentrated at the true genotype across all mixture complexities, and that evidentiary evaluation of single cells renders highly informative forensic comparisons across multifarious admixtures. Probabilistic genotyping software validated for single-cell STR analysis can compute likelihood ratios from clustered single-cell replicates, and studies have shown that probabilistic genotyping of single-cell replicates from complex DNA mixtures recovers higher contributor likelihood ratios than standard analysis. The approach has even been applied to first-degree relatives, where probabilistic genotyping of single-cell replicates prevents the false inclusion of non-donor relatives—a critical safeguard in cases involving family members. Y-chromosomal haplotyping of single sperm cells isolated from semen mixtures has successfully identified three perpetrators in a multi-suspect sexual assault case, and cluster analysis has been used to group partial autosomal haplotypes derived from single sperm STR profiling.

The review also highlights the comparative performance of the three isolation categories across throughput, sample adaptability, and cost. Micromanipulation and LCM offer the finest precision and work directly on stained slides without requiring single-cell suspension, making them adaptable to degraded or limited samples, but their throughput is low and operator skill is essential. FACS and IFC deliver high throughput and quantitative classification but demand intact single-cell suspensions and expensive instrumentation. DEPArray systems provide digital precision and image-based selection but are constrained by cartridge capacity and cost. The authors note that no single technique dominates across all criteria, and the choice depends on the mixture type, the cell types involved, and the resources available. For same-cell-type mixtures—such as blood from two donors or touch DNA from multiple handlers—only single-cell strategies can physically separate the contributors, because differential extraction and other conventional methods rely on cell-type differences that do not exist in these cases.

Looking forward, the Sichuan University team identifies three converging directions that could transform single-cell forensics from a specialized tool into a routine workflow. Automation and high-throughput systems, including deep neural networks for automated sperm detection on stained slides and fully integrated microfluidic sample-in-answer-out platforms, could dramatically reduce the manual labor that currently limits casework. Artificial intelligence-assisted analysis, from convolutional networks that hunt sperm on microscope slides to machine learning models that classify cell types from morphological features, is already demonstrating feasibility in published studies. And standardized interpretation frameworks—the development of validated pipelines for multi-single-cell clustering, consensus genotype reconstruction, and probabilistic evidence evaluation—will be essential for courts to accept single-cell evidence with the same confidence as conventional profiles. The authors emphasize that the forensic value of single-cell strategies is already clear: they can recover probative DNA profile information from unresolvable minor donors, deconvolve same-cell-type mixtures that defeat all other methods, and provide genotype data that concentrates at the true contributor genotype regardless of mixture complexity. As these techniques mature, the review concludes, the combination of automated isolation, AI-assisted analysis, and standardized probabilistic interpretation could finally give investigators the power to read the full genetic story hidden in even the most tangled crime scene sample.

Subject of Research: Forensic Science

Article Title: Single-cell strategies for the interpretation of complex forensic DNA mixtures: isolation techniques, genotype data integration, and prospects for application

Article References: Liu, R., Wang, Z., & Liu, J. (2026). Single-cell strategies for the interpretation of complex forensic DNA mixtures: isolation techniques, genotype data integration, and prospects for application. International Journal of Legal Medicine. https://doi.org/10.1007/s00414-026-04046-y

Image Credits: AI Generated

DOI: 10.1007/s00414-026-04046-y

Keywords: forensic DNA, single-cell analysis, DNA mixtures, STR profiling, laser capture microdissection, FACS, DEPArray, probabilistic genotyping, forensic science, legal medicine, Single-cell, strategies

Broiler stunting diseases have long frustrated veterinary virologists. Runting-stunting syndrome, often abbreviated as RSS, is associated with malabsorption and typically presents in young chicks as stunted growth, poor feathering and abnormal droppings. A related but distinct condition, transmissible viral proventriculitis or TVP, involves maldigestion linked to inflammation of the proventriculus, the glandular stomach of the bird. Viral infections have repeatedly been proposed as contributors to both syndromes, and numerous candidate agents have been put forward over the decades. Yet the aetiological roles of specific viruses remain obscure. Conventional virome studies, which typically sequence viral genetic material from homogenised whole tissues or faecal samples, lack spatial resolution. They cannot determine which viruses are physically localised to lesion sites and which are merely passing through the gut lumen, a limitation that severely constrains inference about direct viral involvement in pathogenesis.

The team’s methodological innovation was to couple laser-capture microdissection of formalin-fixed paraffin-embedded tissues with metatranscriptomic sequencing. Formalin-fixed paraffin-embedded, or FFPE, tissues are the standard material of diagnostic histopathology, preserving cellular architecture so that pathologists can score lesions and identify affected regions. Using a laser microdissection system, the researchers excised histologically defined lesion areas from four regions of the gastrointestinal tract, the duodenum, jejunum, proventriculus and gizzard, alongside matching unaffected non-lesion regions from the same tissue sections. This design meant that viral communities within lesions could be compared directly with those in adjacent healthy tissue within the same birds and the same flocks, effectively using each animal as its own experimental control and filtering out background viral noise from feed, environment and commensal carriage.

The sequencing generated a rich catalogue of viral operational taxonomic units across the sampled tissues. In the RSS-derived laser-microdissected samples, which totalled 71 distinct lesion and non-lesion preparations, three enteric viruses emerged as consistently enriched within gastrointestinal lesion tissues relative to non-lesion tissues. The first was Gallivirus spp., detected as multiple strains, a genus of small RNA viruses that has circulated in poultry for years without a clearly defined disease role. The second was Avastrovirus galli, an avian astrovirus species known to infect the intestinal tract. The third was Rotavirus deltagastroenteritidis, a member of the rotavirus species that infects the gastrointestinal systems of birds. All three belong to virus groups long suspected of involvement in enteric disease, but this study provided the spatial evidence that conventional approaches could not deliver: their genetic material concentrates precisely where the tissue damage is.

Importantly, these candidate viruses were not confined to a single outbreak. The researchers detected them across multiple affected farms, and in individual lesion samples the viruses co-occurred, suggesting that co-infections may contribute to the development or severity of stunting disease. This pattern of co-occurrence raises questions familiar from other enteric disease systems, where combinations of viruses, rather than any single agent, may overwhelm the gut’s absorptive capacity or immune defences. The consistency of enrichment across farms strengthens the case that these three viruses are meaningfully associated with RSS pathology rather than being incidental findings, although the authors are careful to frame them as candidate agents whose causal roles still require further investigation.

A particularly revealing component of the study came from the comparative analysis with transmissible viral proventriculitis. The team analysed 49 laser-microdissected samples derived from TVP cases and found that the enteric virome compositions of the two syndromes were clearly distinct. Differential enrichment of vaccine-like strains was observed in the TVP samples, indicating that live attenuated vaccine viruses may occupy a different ecological or pathological niche in this maldigestion-associated condition. The contrast between the RSS and TVP viral signatures confirmed that the spatially informed approach can discriminate disease-specific viral profiles, a proof of principle that extends beyond this single question. Where two clinically related but pathologically distinct syndromes could previously be interrogated only with blunt whole-tissue sequencing, the lesion-anchored method now separates their viromes with histological precision.

Suspicions raised by sequencing were then tested against independent material. All three RSS candidate viruses were confirmed in matched fresh-frozen tissue homogenates from the same birds using reverse transcription PCR, quantitative RT-PCR and amplicon sequencing, verifying that the microdissection findings were not artefacts of FFPE processing or sequencing bias. The researchers went a step further and attempted virus isolation, successfully recovering chicken astrovirus in cell culture. This chain of evidence, from histological lesion to spatially resolved viral sequence to independent molecular confirmation in frozen tissue to live virus in culture, represents a rigorous workflow for implicating candidate pathogens in a disease complex that has resisted definitive attribution for decades.

The technical achievement rests on careful handling of a notoriously difficult sample type. FFPE tissue is chemically preserved and fragmented, which complicates RNA extraction and library preparation, and laser-capture microdissection demands expert histological guidance to distinguish lesion from non-lesion tissue reliably. The authors acknowledge the histological laboratory of the Agri-Food and Biosciences Institute at Stormont for preparing tissue samples, and Professor Imre Lengyel and Dr Jamie Mitchell of Queen’s University Belfast’s Wellcome Wolfson Institute for Experimental Medicine for training and laboratory support in the microdissection experiments. The work was funded by the UK Biotechnology and Biological Sciences Research Council under grant number BB/X01732X/1, with additional collaboration from the Animal and Plant Health Agency and St. David’s poultry team in clinical diagnosis, post-mortem investigation and tissue sample preparation.

The significance of the framework extends beyond the broiler house. Spatially informed viromics, as the authors describe it, moves beyond conventional virome surveys by linking viral abundance patterns to histopathological context, converting a list of detected viruses into a map of where each virus resides relative to tissue injury. The same logic applies to any disease in which a virome has been catalogued but causation remains contested, from respiratory infections in livestock to chronic inflammatory conditions in humans where archived biopsy material is abundant. By demonstrating that lesion-anchored analysis can separate disease-specific viral signatures between two syndromes in the same host species, the study establishes a template for turning diagnostic pathology archives into high-resolution virological evidence.

For the poultry industry, the immediate value lies in the candidate agents themselves. Gallivirus, avian astrovirus and the avian rotavirus now have concrete spatial and molecular evidence tying them to RSS lesions across multiple farms, giving researchers specific targets for experimental infection studies, vaccine development and diagnostic assay design. The open question the authors highlight is whether these viruses function as primary pathogens or as co-factors that act alongside other infectious or husbandry-related stresses to produce stunting disease. Answering that question will require controlled challenge experiments and longitudinal field work, but for the first time those experiments can be aimed at a shortlist of candidates selected not merely by abundance in a sequencing library but by their physical presence within the lesions where the damage is done.

Subject of Research: Spatial viromics of broiler stunting disease lesions to identify candidate viral pathogens

Article Title: Lesion-anchored viromics identifies candidate viral agents of broiler stunting diseases

Article References: Hsieh, S.-Y., Creevey, C. J., Sheridan, P. M., Poulos, C. G., Smyth, V. J., & Kyriazakis, I. (2026). Lesion-anchored viromics identifies candidate viral agents of broiler stunting diseases. Microbiome. https://doi.org/10.1186/s40168-026-02556-w

Image Credits: AI Generated

DOI: 10.1186/s40168-026-02556-w

Keywords: broiler, runting-stunting syndrome, transmissible viral proventriculitis, viromics, metatranscriptomics, laser-capture microdissection, astrovirus, rotavirus, gallivirus, poultry health, viral enteritis, histopathology

The Balbiani body, often abbreviated as the B-body or Bb, is a cloud of RNA, proteins, and organelles that appears in the cytoplasm of young oocytes across a striking range of animals, from fruit flies to frogs to humans. Although its existence has been known since the nineteenth century, its exact molecular recipe has remained elusive, particularly outside a handful of classic model organisms. In fish, another related structure called nuage—a diffuse, electron-dense material associated with germ cells—complicates the picture. Both structures are membraneless, which means they cannot simply be plucked out of a cell with conventional biochemical tools, and their components intermingle with the surrounding cytoplasm in ways that frustrate isolation.

To overcome this technical barrier, the team led by Ji Liu, Xi Wu, and Jian Luo of Hainan University turned to laser capture microdissection, a technique that uses a precision laser to excise specific regions from tissue sections mounted on a microscope slide. Working with the Leica LMD7000 system at the Ocean University of China, the researchers carved out the Balbiani body region from oocytes at different developmental stages. Because the nuage proved too difficult to isolate reliably on its own, they instead dissected the nucleus together with the surrounding nuage, creating what they call a nuage-associated nucleus-containing region, or NNR. This pragmatic compromise allowed them to profile the nuage neighborhood while acknowledging that nuclear molecules would inevitably contaminate the signal.

The ultrastructural work, carried out with electron microscopy, established the timeline of events. Nuage material was present from the earliest oogonial stages and persisted throughout oocyte development. The Balbiani body, by contrast, made its appearance specifically in primary oocytes, where it gradually expanded before dispersing its contents into the surrounding cytoplasm. This choreography—formation, expansion, and dispersion—mirrors what has been described in other species and suggests a conserved role in preparing the egg with maternal materials that the early embryo will depend on before its own genes switch on.

On the molecular side, the researchers applied Smart-seq2, a highly sensitive method for sequencing the RNA of individually captured cells or compartments, alongside data-independent acquisition proteomics, or DIA, which quantifies thousands of proteins in a sample by systematically fragmenting all peptides within defined mass windows. Running both technologies on the same microdissected regions allowed the team to compare the transcriptomic and proteomic landscapes directly. The result was revealing: across the different Balbiani body stages, RNA levels changed relatively little, but the protein complement shifted much more dramatically. This decoupling suggests that post-transcriptional regulation—proteins being made, modified, or degraded without corresponding changes in messenger RNA—dominates the maturation of the granule, a theme that resonates with the B-body’s known function as a site of stored, translationally repressed maternal transcripts.

The NNR samples, meanwhile, showed molecular variation that tracked with developmental stage, consistent with the changing composition of the nuage that surrounds the nucleus as oocytes age. The compartment-biased expression of established marker molecules matched what is already known about Balbiani body biology, lending confidence to the microdissection strategy. The authors are careful, however, to flag the limits of the NNR data: because the dissected region includes the nucleus, any functional signals detected there must be treated as exploratory rather than definitive. Nuclear transcripts and proteins inevitably dominate such samples, and disentangling genuine nuage components from nuclear background will require more refined approaches in future work.

Perhaps the most consequential finding of the study is the identification and validation of two candidate Balbiani body markers: Ddx6 and Igf2bp3. Ddx6 encodes a DEAD-box RNA helicase, a class of enzymes best known for remodeling RNA structures and regulating translation, and it has well-documented roles in germ granules across the animal kingdom. Igf2bp3, a member of the insulin-like growth factor 2 mRNA-binding protein family, is an oncofetal RNA-binding protein that has been implicated in RNA localization and stability. In the grouper oocytes, both the messenger RNAs and the proteins corresponding to these two genes localized precisely to the Balbiani body region under the microscope. Even more strikingly, their localization shifted over time in lockstep with the granule’s own life cycle—appearing as the B-body formed, tracking its expansion, and dispersing as the structure dissolved into the cytoplasm.

This stage-dependent co-localization makes Ddx6 and Igf2bp3 valuable new tools for the field. Reliable markers are the currency of organelle biology: they allow researchers to track a structure’s dynamics in live tissue, to test whether candidate interactors genuinely join the compartment, and to compare granule composition across species and developmental contexts. For fish, where the Balbiani body has been far less characterized than in frogs or flies, adding two validated markers to the repertoire represents a meaningful expansion of the experimental toolkit. It also opens the door to functional studies—knockdown or knockout experiments could now ask what happens to oocyte quality and embryonic development when these granule components are removed.

The choice of species matters as much as the methods. The leopard coral grouper, Plectropomus leopardus, is one of the most prized reef fish in Asian aquaculture, and its seed production depends on high-quality eggs whose developmental potential is laid down during oogenesis. Understanding the molecular machinery that packages maternal determinants into the oocyte could eventually inform hatchery practices, broodstock management, and breeding programs. The study was supported by funding from the Sanya Yazhou Bay Science and Technology City project, the National Natural Science Foundation of China’s Regional Innovation and Development Joint Fund, and several Hainan provincial programs, reflecting the region’s investment in marine breeding science.

Beyond aquaculture, the work speaks to a broader question in cell biology: how membraneless compartments, held together by weak multivalent interactions rather than lipid bilayers, achieve precise composition and timing. The Balbiani body is a natural model for this problem, assembling at a specific place and time, carrying a defined cargo, and then dissolving on schedule. By pairing spatially resolved microdissection with dual transcriptomic and proteomic profiling, the grouper study demonstrates a framework that other researchers can adapt to any tissue where membraneless granules are too small or too intermingled for conventional purification. The authors themselves emphasize that the nuage remains the next frontier—its molecular composition, and its possible relationship with the Balbiani body, await isolation methods sharp enough to capture it alone. Until then, the dynamic portrait of Ddx6 and Igf2bp3 tracing the granule’s rise and fall offers a vivid glimpse of how an egg builds the seed of an embryo, one molecular granule at a time.

Subject of Research: Molecular characterization of Balbiani body formation during oocyte development in leopard coral grouper

Article Title: Integrative analysis of Smart-seq2 and DIA proteomics reveals dynamic formation of the Balbiani body during oocyte development in leopard coral grouper (Plectropomus leopardus)

Article References: Liu, J., Wang, G., Zhang, X., Wu, X., Zhang, X., Zheng, T., Wen, X., Wu, X., & Luo, J. (2026). Integrative analysis of Smart-seq2 and DIA proteomics reveals dynamic formation of the Balbiani body during oocyte development in leopard coral grouper (Plectropomus leopardus). BMC Genomics. https://doi.org/10.1186/s12864-026-13414-2

Image Credits: AI Generated

DOI: 10.1186/s12864-026-13414-2

Keywords: Balbiani body, oocyte development, nuage, laser capture microdissection, Smart-seq2, DIA proteomics, Ddx6, Igf2bp3, leopard coral grouper, germ granules, oogenesis, membraneless organelles

Mass spectrometry-based amyloid typing has earned a reputation as the gold standard for identifying the amyloidogenic protein in tissue deposits. By shredding laser-microdissected amyloid plaques into peptides and reading their mass spectra, laboratories can distinguish among more than thirty amyloid types with a specificity that immunohistochemistry and immunofluorescence simply cannot match. Yet the technique has remained confined largely to a handful of reference laboratories because it depends on nanoflow liquid chromatography, in which solvents are pushed through capillaries with inner diameters measured in tens of micrometers. Nanoflow systems deliver exquisite sensitivity, but they come with steep up-front costs, demanding maintenance, long column equilibration times, and a level of operational complexity that deters routine clinical adoption.

The Stanford team, led by Morgan W. Mann and Fangjun Chen with senior authors Megan L. Troxell and Ruben Y. Luo, set out to re-engineer the workflow so that it could run on the high-flow liquid chromatography systems already humming away in hospital laboratories. Their solution rests on two complementary innovations: a sample preparation method called suspension trapping, known commercially as S-Trap, and an acquisition strategy known as data-independent acquisition, or DIA. Together, these techniques allow the analysis of microdissected amyloid plaques using conventional-flow chromatography coupled to tandem mass spectrometry, without sacrificing the diagnostic accuracy that clinicians rely upon.

Suspension trapping is the quieter revolution of the two. In traditional proteomics sample preparation, proteins extracted from tiny tissue fragments must be digested into peptides through a series of solution exchanges, buffer removals, and cleanups that consume time and lose precious material at every step. The S-Trap approach instead traps proteins on a quartz filter matrix as they precipitate out of an acidic methanol-containing buffer. Digestion enzymes then pass through the trap, generating peptides that are eluted in a single, efficient step. The method is fast, robust, and minimizes sample loss, which matters enormously when the starting material consists of a few thousand cells harvested by laser capture microdissection from a formalin-fixed paraffin-embedded tissue section.

Data-independent acquisition addresses the other half of the problem. In classical data-dependent acquisition, the mass spectrometer selects the most intense ions in each scan for fragmentation, a stochastic process that can miss low-abundance peptides and produces data that are tedious to align across runs. DIA, by contrast, fragments all ions within successive wide mass windows, systematically recording fragment spectra for essentially everything in the sample. The resulting data are reconstructed computationally against spectral libraries, yielding consistent and quantitative peptide identifications. Because DIA tolerates the higher flow rates, wider chromatographic peaks, and greater sample loads of high-flow chromatography, it made the leap away from nanoflow feasible rather than merely aspirational.

To translate raw proteomic data into a diagnosis, the researchers also developed a custom selection heuristic that sifts through the hundreds of proteins detected in each plaque and identifies the most likely amyloidogenic culprit. Amyloid deposits are not pure; they sweep up serum proteins, immunoglobulin fragments, and extracellular matrix components as they form. Distinguishing the genuine amyloidogenic protein from innocent bystanders requires weighing total protein abundance, the presence of type-specific signature peptides, and the biological plausibility of each candidate. The heuristic automates this judgment, reducing an expert curation task that could take hours into a reproducible computational step suitable for a busy clinical workflow.

The performance data are striking. Working with laser capture microdissected plaques from 47 patient samples, 10 from cardiac biopsies and 37 from renal biopsies, the team split the material into a training set of 25 samples and an independent testing set of 22. The high-flow LC-DIA-MS/MS method identified the amyloidogenic protein in approximately 96 percent of plaques in both sets, a success rate comparable to established nanoflow approaches. The two inaccuracies observed across the cohort both traced to difficulties in identifying immunoglobulin lambda proteins, once in a specimen obtained after treatment had altered the composition of the deposits and once in a plaque containing two distinct amyloid types simultaneously. These edge cases, the authors note, define the boundaries of the method rather than undermining its general utility.

Reducing the sample preparation workflow to under eight hours carries practical significance beyond convenience. Amyloidosis is increasingly recognized as an urgent diagnosis; cardiac involvement can progress rapidly, and new therapies such as transthyretin stabilizers and silencing agents work best when started early. Every hour shaved from the analytical pipeline shortens the time between biopsy and answer. Equally important, the shift to high-flow chromatography means the method can run on instruments of the kind already deployed for clinical chemistry assays, drug monitoring, and newborn screening in hospital laboratories. That compatibility could transform amyloid typing from a rarefied referral test into an accessible diagnostic performed locally, at lower cost and with faster turnaround.

The study, published in Clinical Proteomics, was conducted on remnant patient specimens under approved institutional review board protocols and funded through the Stanford University Department of Pathology’s Test Development Program, underscoring its explicitly clinical orientation. The authors acknowledge one commercial entanglement: a collaborative research relationship between one investigator and Thermo Fisher Scientific, which provided technical support. While the method will still require validation in other laboratories and across broader panels of amyloid types, the combination of suspension trapping, data-independent acquisition, and high-flow chromatography represents a credible path toward democratizing molecular amyloid typing, offering patients everywhere the prospect of a faster, more precise answer to the question their treatment ultimately depends on.

Subject of Research: A high-flow liquid chromatography-tandem mass spectrometry method for typing amyloidosis in clinical laboratories

Article Title: Suspension trapping and data-independent acquisition enable high-flow liquid chromatography-tandem mass spectrometry-based amyloidosis typing in clinical laboratories

Article References: Mann, M. W., Chen, F., Zhu, C., Lu, C., Liang, B., Kambham, N., Troxell, M. L., & Luo, R. Y. (2026). Suspension trapping and data-independent acquisition enable high-flow liquid chromatography-tandem mass spectrometry-based amyloidosis typing in clinical laboratories. Clinical Proteomics. https://doi.org/10.1186/s12014-026-09628-x

Image Credits: AI Generated

DOI: 10.1186/s12014-026-09628-x

Keywords: amyloidosis, mass spectrometry, proteomics, data-independent acquisition, suspension trapping, liquid chromatography, clinical diagnostics, laser capture microdissection, AL amyloidosis, ATTR amyloidosis, tandem mass spectrometry, clinical proteomics